Attunio Health Launches AI Precision Psychiatry Platform

Attunio Health has introduced a precision psychiatry platform that integrates artificial intelligence, biomarker testing, and wearable data to personalize mental health care, according to a press release. The platform aims to move psychiatric treatment from symptom-based assessments toward continuous, data-driven personalization.

The system collects data from multiple sources including wearable devices that track sleep, recovery, heart rate variability, and stress, as well as lab panels measuring metabolic, hormonal, and nutritional biomarkers. It also incorporates continuous glucose monitoring, genetic data, and behavioral reporting. These inputs are analyzed through Attunio’s proprietary intelligence engine to identify biological and behavioral patterns that influence focus, mood, and cognitive performance.

Clinicians within the Attunio network review AI-generated insights alongside patient data to guide treatment decisions. The platform’s closed-loop clinical intelligence enables continuous feedback between patient progress and care adjustments, allowing early detection of changes such as sleep decline, elevated stress, or medication response shifts.

Attunio Health stated that it is building infrastructure to support widespread access to diagnostics, remote monitoring, and clinician-guided precision treatment, positioning the platform as a model for adaptive and measurable mental healthcare.